Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 101Specimen Handling 83pembrolizumab 76enzalutamide 63Nivolumab 59Gemcitabine 56Docetaxel 50apalutamide 42Radiosurgery 42Abiraterone Acetate 40Prednisone 39Androgen Antagonists 39Cisplatin 37Biopsy 37darolutamide 36cabozantinib 32Radiotherapy 32Pluvicto 28Carboplatin 28abiraterone 27Ipilimumab 25enfortumab vedotin 24durvalumab 24Radiation 23atezolizumab 22X-Rays 21Leuprolide 20Standard of Care 19olaparib 18avelumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Accelerometry × Genitourinary × 90 days × Clear all
NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Ohio State University Comprehensive Cancer Center

Phase 4 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡